➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Last Updated: June 2, 2020

DrugPatentWatch Database Preview

Watson Labs Teva Company Profile

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for WATSON LABS TEVA, and what generic and branded alternatives to WATSON LABS TEVA drugs are available?

WATSON LABS TEVA has forty-nine approved drugs.

There are two tentative approvals on WATSON LABS TEVA drugs.

Summary for Watson Labs Teva
US Patents:0

Drugs and US Patents for Watson Labs Teva

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs Teva BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE bisoprolol fumarate; hydrochlorothiazide TABLET;ORAL 075469-001 Sep 25, 2000 DISCN No No   Start Trial   Start Trial
Watson Labs Teva CIMETIDINE cimetidine TABLET;ORAL 075425-001 Jul 29, 1999 DISCN No No   Start Trial   Start Trial
Watson Labs Teva ESTROPIPATE estropipate TABLET;ORAL 081215-001 Sep 23, 1993 DISCN No No   Start Trial   Start Trial
Watson Labs Teva TEMOZOLOMIDE temozolomide CAPSULE;ORAL 203959-005 Apr 18, 2017 AB RX No No   Start Trial   Start Trial
Watson Labs Teva TRIENTINE HYDROCHLORIDE trientine hydrochloride CAPSULE;ORAL 207567-001 Feb 7, 2018 AB RX No No   Start Trial   Start Trial
Watson Labs Teva DEXAMETHASONE ACETATE dexamethasone acetate INJECTABLE;INJECTION 087711-001 May 24, 1982 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.